Title

CXCR3 Depleting Antibodies Prevent and Reverse Vitiligo in Mice

UMMS Affiliation

Department of Medicine, Division of Dermatology; UMass Metabolic Network

Date

4-1-2017

Document Type

Article

Disciplines

Biochemistry | Cell Biology | Cellular and Molecular Physiology | Dermatology | Molecular Biology | Skin and Connective Tissue Diseases

Abstract

Therefore, we sought to determine if targeting CXCR3 could serve as a new treatment for vitiligo.

Rights and Permissions

Citation: J Invest Dermatol. 2017 Apr;137(4):982-985. Epub 2017 Jan 23. Link to article on publisher's site

Related Resources

Link to Article in PubMed

PubMed ID

28126463